CD4 and breast cancer: The presence of circulating serum-derived EVs from healthy volunteers and BC patients in vitro resulted in a decrease in the frequency of CD3+CD4+HLA-DR+ (Figure 3C) and CD3+CD8+HLA-DR+ T cells (Figure 3D).